DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Chaignot C, Zureik M, Rey G. et al
Risk of hospitalization and death related to baclofen for alcohol use disorders: Comparison with nalmefene acamprosate and naltrexone in a cohort study of 165334 patients between 2009 and 2015 in France.
Pharmacoepidemiol Drug Saf 2016;
27: 1239-1248
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.